Revenue Breakdown
Composition ()
No data
Revenue Streams
Labcorp Holdings Inc (LH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is DX, accounting for 77.9% of total sales, equivalent to $2.75B. Other significant revenue streams include BLS and Intercompany eliminations. Understanding this composition is critical for investors evaluating how LH navigates market cycles within the Healthcare Facilities & Services industry.
Profitability & Margins
Evaluating the bottom line, Labcorp Holdings Inc maintains a gross margin of 26.82%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 11.31%, while the net margin is 7.34%. These profitability ratios, combined with a Return on Equity (ROE) of 10.14%, provide a clear picture of how effectively LH converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, LH competes directly with industry leaders such as GH and SOLV. With a market capitalization of $22.41B, it holds a leading position in the sector. When comparing efficiency, LH's gross margin of 26.82% stands against GH's 64.71% and SOLV's 54.06%. Such benchmarking helps identify whether Labcorp Holdings Inc is trading at a premium or discount relative to its financial performance.
